跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VERSATIS lidocaine (lignocaine) 5% w/w dermal patch - TGA Drug Approval Details
Approvals
/
TGA
/
VERSATIS lidocaine (lignocaine) 5% w/w dermal patch
Approved
STANDARD
VERSATIS lidocaine (lignocaine) 5% w/w dermal patch
Seqirus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
0b2d9d05e95a006f
Company
Seqirus Pty Ltd
Type
Standard
Approval Details
Approval Id
0b2d9d05e95a006f
Product Name
VERSATIS lidocaine (lignocaine) 5% w/w dermal patch
Artg Id
175178
Artg Name
VERSATIS lidocaine (lignocaine) 5% w/w dermal patch
Sponsor
Seqirus Pty Ltd
Company Detail Path
/organization/seqirus-pty-ltd
Artg Date
2012-03-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/3154c0a3397375c69e913c1b597d4165.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/7b998f327f90dd79e0c19f7407455dc3.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
0b2d9d05e95a006f
Type
Standard
Back to TGA Approvals